Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis
Annals of Clinical and Translational Neurology · 2024
DOI: 10.1002/acn3.52025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Kaarina Kowalec und 22 weiteren Autor:innen. Beteiligte Einrichtung: Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. Hauptthemen laut MEDLINE: Multiple Sclerosis, Multifactorial Inheritance, Comorbidity, Anxiety Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bingham Chair in Gastroenterology, US Department of Veterans Affairs, Waugh Family Chair in Multiple Sclerosis.
Abstract (Originalsprache)
Objective
Comorbid anxiety occurs often in MS and is associated with disability progression. Polygenic scores offer a possible means of anxiety risk prediction but often have not been validated outside the original discovery population. We aimed to investigate the association between the Generalized Anxiety Disorder 2‐item scale polygenic score with anxiety in MS.
Methods
Using a case–control design, participants from Canadian, UK Biobank, and United States cohorts were grouped into cases (MS/comorbid anxiety) or controls (MS/no anxiety, anxiety/no immune disease or healthy). We used multiple anxiety measures: current symptoms, lifetime interview‐diagnosed, and lifetime self‐report physician‐diagnosed. The polygenic score was computed for current anxiety symptoms using summary statistics from a previous genome‐wide association study and was tested using regression.
Results
A total of 71,343 individuals of European genetic ancestry were used: Canada ( n = 334; 212 MS), UK Biobank ( n = 70,431; 1,390 MS), and the USA ( n = 578 MS). Meta‐analyses identified that in MS, each 1‐SD increase in the polygenic score was associated with ~50% increased odds of comorbid moderate anxious symptoms compared to those with less than moderate anxious symptoms (OR: 1.47, 95% CI: 1.09–1.99). We found a similar direction of effects in the other measures. MS had a similar anxiety genetic burden compared to people with anxiety as the index disease.
Interpretation
Higher genetic burden for anxiety was associated with significantly increased odds of moderate anxious symptoms in MS of European genetic ancestry which did not differ from those with anxiety and no comorbid immune disease. This study suggests a genetic basis for anxiety in MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
- Department of Medical Epidemiology & Biostatistics, Karolinska Institutet, Solna, Sweden.
- Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
- Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- Department of Neurology, UT Southwestern, Dallas, Texas, USA.
- Department of Psychiatry, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
ORCID-Profile: Kaarina Kowalec, Kathryn C Fitzgerald, Amber Salter, Kyla A McKay, Jerry S Wolinsky
Förderung
- Bingham Chair in Gastroenterology
- US Department of Veterans Affairs
- Waugh Family Chair in Multiple Sclerosis
- NIMH NIH HHS
- Department of Defense Congressionally Directed Medical Research Program
- Consortium of Multiple Sclerosis Centers
- CIHR
- University of Manitoba
Zitieren
APA
Kowalec, K., Harder, A., Dolovich, C., Fitzgerald, K. C., Salter, A., Lu, Y., Bernstein, C. N., Bolton, J. M., Cutter, G., Fisk, J. D., Gelernter, J., Graff, L. A., Hägg, S., Hitchon, C. A., Levey, D. F., Lublin, F. D., McKay, K. A., Patten, S., Patki, A., …, & Marrie, R. A. (2024). Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52025
Vancouver
Kowalec K, Harder A, Dolovich C, Fitzgerald KC, Salter A, Lu Y, et al. Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52025
BibTeX
@article{Kowalec2024,
author = {Kowalec, Kaarina and Harder, Arvid and Dolovich, Casandra and Fitzgerald, Kathryn C and Salter, Amber and Lu, Yi and Bernstein, Charles N and Bolton, James M and Cutter, Gary and Fisk, John D and Gelernter, Joel and Graff, Lesley A and Hägg, Sara and Hitchon, Carol A and Levey, Daniel F and Lublin, Fred D and McKay, Kyla A and Patten, Scott and Patki, Amit and Stein, Murray B and Tiwari, Hemant K and Wolinsky, Jerry S and Marrie, Ruth A},
title = {Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis},
journal = {Annals of Clinical and Translational Neurology},
year = {2024},
doi = {10.1002/acn3.52025}
}
EUVIMED